A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer
- 1 April 1983
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 15 (2) , 261-277
- https://doi.org/10.1016/0090-8258(83)90082-3
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinomaGynecologic Oncology, 1982
- Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaCancer, 1980
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaCancer, 1978
- Melphalan Chemotherapy in Advanced Ovarian CarcinomaObstetrics & Gynecology, 1978
- Chemotherapy of ovarian cancer. New Approaches to TreatmentCancer, 1972
- Chemotherapy in the treatment of cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1970
- CYCLOPHOSPHAMIDE IN THE TREATMENT OF OVARIAN CANCERClinical Obstetrics and Gynecology, 1968
- Chemotherapy for advanced ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1966
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958